Skip to main content

Table 1 Characteristics of the patients with Kawasaki disease (KD) and healthy children (control group)

From: Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Characteristic Kawasaki disease Control
  Acute stage P Afebrile stage P Subacute stage P  
Boys/girls, number 22/18 NS 11/4
Age, months (range) 23.2 (5.1-72.0) NS 63.7 (2.6-109.0)
Days of fever (range) 6.3 (3.0-15.0) -- --
Resistin, 102 ng/ml 0.38 (0.25) 0.001 0.24 (0.22) ** 0.360 0.14 (0.09) ** 0.405 0.19 (0.16)
S100A12, 102 ng/ml 5.33 (3.23) 0.001 4.07 (3.52) * 0.031 2.62 (2.64) ** 0.542 2.05 (1.81)
sRAGE, 102 pg/ml 3. 00 (1.91) 0.000 5.75 (2.83) ** 0.001 6.83 (3.07) ** 0.018 9.04 (5.28)
Resistin × S100A12, 104 2.61 (2.58) 0.000 1.20 (1.19) ** 0.122 0.24 (0.23) ** 0.877 0.32 (0.26)
Resistin/sRAGE, 102 2.13 (1.89) 0.000 0.39 (0.28) ** 0.708 0.21 (0.14) ** 0.884 0.26 (0.21)
S100A12/sRAGE, 103 2.61 (2.02) 0.000 0.84 (0.69) ** 0.107 0.30 (0.25) ** 0.835 0.23 (0.19)
WBCs, 104/ul 1.39 (0.49) -- 1.01 (0.51) ** -- 1.01 (0.51) ** -- --
Neutrophils, % 55.6 (18.8) -- 33.2 (17.2) ** -- 33.4 (17.6) ** -- --
Lymphocytes, % 32.5 (15.1) -- 50.9 (16.6) ** -- 54.3 (16.7) ** -- --
Monocytes, % 7.81 (3.98) -- 11.6 (16.6) -- 8.77 (2.94) -- --
Platelets, 105/ul 4.23 (1.44) -- 5.68 (2.09) ** -- 6.79 (1.87) **▲▲ -- --
CRP, mg/l 75.1 (49.1) -- 25.0 (33.8) ** -- 3.25 (4.12) **▲▲ -- --
ESR, mm/h 67.7 (29.7) -- 78.8 (30.4) ** -- 59.2 (28.3) ▲▲ -- --
  1. Results are mean (SD) unless stated otherwise. All P-values are for patients versus healthy controls. NS, not significant; sRAGE, soluble receptor for advanced glycation end products; WBCs, white blood cells; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate. *P < 0.05, **P < 0.01 compared with acute stage; P < 0.05, ▲▲P < 0.01 compared with afebrile stage.